Second-line chemotherapy in patients with primary unknown cancerONO, Makiko; ANDO, Masashi; YONEMORI, Kan et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 8, pp 1185-1191, issn 0171-5216, 7 p.Article

A population-based review of the feasibility of platinum-based combination chemotherapy after tyrosine kinase inhibition in EGFR mutation positive non-small cell lung cancer patients with advanced diseaseMARIANO, Caroline; BOSDET, Ian; KARSAN, Aly et al.Lung cancer. 2014, Vol 83, Num 1, pp 73-77, issn 0169-5002, 5 p.Article

Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 studyAULIAC, J. B; CHOUAID, C; SCHOTT, R et al.Lung cancer. 2014, Vol 85, Num 3, pp 415-419, issn 0169-5002, 5 p.Article

Second-line treatment for advanced non-small cell lung cancer : A systematic reviewBARLESI, Fabrice; JACOT, William; ASTOUL, Philippe et al.Lung cancer. 2006, Vol 51, Num 2, pp 159-172, issn 0169-5002, 14 p.Article

What's new in the treatment of advanced prostate cancer?STERNBERG, C. N.European journal of cancer (1990). 2003, Vol 39, Num 2, pp 136-146, issn 0959-8049, 11 p.Article

Navigating later lines of treatment for advanced colorectal cancer - Optimizing targeted biological therapies to improve outcomesGILL, Sharlene; DOWDEN, Scot; COLWELL, Bruce et al.Cancer treatment reviews. 2014, Vol 40, Num 10, pp 1171-1181, issn 0305-7372, 11 p.Article

A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancerMORIZANE, Chigusa; OKUSAKA, Takuji; FURUSE, Junji et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 2, pp 313-319, issn 0344-5704, 7 p.Article

A Pilot Trial of Docetaxel and Nedaplatin in Cisplatin-Pretreated Relapsed or Refractory Esophageal Squamous Cell CancerNAKAJIMA, Yasuaki; SUZUKI, Tomoyoshi; HARUKI, Shigeo et al.Hepato-gastroenterology. 2008, Vol 55, Num 86-87, pp 1631-1635, issn 0172-6390, 5 p.Article

Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen. CommentaryKOUNO, Tsutomu; ANDO, Masashi; FUJIWARA, Yasuhiro et al.European urology. 2007, Vol 52, Num 4, pp 1115-1122, issn 0302-2838, 8 p.Article

Metastatic melanoma: results of 'classical' second-line treatment with cytotoxic chemotherapiesPERRIN, Christophe; PRACHT, Marc; LEFEUVRE-PLESSE, Claudia et al.Journal of dermatological treatment. 2014, Vol 25, Num 5, pp 396-400, issn 0954-6634, 5 p.Article

Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?GRONLUND, B; HANSEN, H. H; HØGDALL, C et al.British journal of cancer. 2004, Vol 90, Num 2, pp 377-382, issn 0007-0920, 6 p.Article

Profile of HIV-infected patients receiving second-line antiretroviral therapy in a resource-limited setting in NigeriaONYEDUM, Cajetan C; IROEZINDU, Michael O; CHUKWUKA, Chinwe J et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 2013, Vol 107, Num 10, pp 608-614, issn 0035-9203, 7 p.Article

Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancerXENIDIS, N; NEANIDIS, K; AMARANTIDIS, K et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 1, pp 69-73, issn 0344-5704, 5 p.Article

High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma PatientsSOO HYEON LEE; MYUNG HEE CHANG; KYUNG KEE BAEK et al.Oncology. 2011, Vol 80, Num 3-4, pp 257-261, issn 0030-2414, 5 p.Article

Second-line erlotinib in patients with advanced non-small-cell lung cancer: Subgroup analyses from the TRUST studyHEIGENER, David F; WU, Yi-Long; VAN ZANDWIJK, Nico et al.Lung cancer. 2011, Vol 74, Num 2, pp 274-279, issn 0169-5002, 6 p.Article

Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancerHENSING, Thomas A; SCHELL, Michael J; LEE, Ji-Hyun et al.Lung cancer. 2005, Vol 47, Num 2, pp 253-259, issn 0169-5002, 7 p.Article

Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trialNIHO, Seiji; KUBOTA, Kaoru; GOTO, Koichi et al.Cancer chemotherapy and pharmacology. 2003, Vol 52, Num 1, pp 19-24, issn 0344-5704, 6 p.Article

Second-line chemotherapy in advanced biliary cancer: a systematic reviewLAMARCA, A; HUBNER, R. A; RYDER, W. David et al.Annals of oncology. 2014, Vol 25, Num 12, pp 2328-2338, issn 0923-7534, 11 p.Article

FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II studyZANIBONI, Alberto; AITINI, Enrico; LABIANCA, Roberto et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 6, pp 1641-1645, issn 0344-5704, 5 p.Article

Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer ― A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)THUSS-PATIENCE, Peter C; KRETZSCHMAR, Albrecht; BICHEV, Dmitry et al.European journal of cancer (1990). 2011, Vol 47, Num 15, pp 2306-2314, issn 0959-8049, 9 p.Article

A modular Phase I study of lenalidomide and paclitaxel in metastatic castration-resistant prostate cancer following prior taxane therapyMATHEW, P; TANNIR, N; TU, S. M et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 4, pp 811-815, issn 0344-5704, 5 p.Article

Trends in chemotherapy for elderly patients with advanced non-small-cell lung cancerYOUNG HAK KIM; YOH, Kiyotaka; NIHO, Seiji et al.Respiratory medicine. 2010, Vol 104, Num 3, pp 434-439, issn 0954-6111, 6 p.Article

Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancerEISEN, Tim; THATCHER, Nick; LEYVRAZ, Serge et al.Lung cancer. 2009, Vol 64, Num 1, pp 60-65, issn 0169-5002, 6 p.Article

The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesotheliomaSTEBBING, Justin; POWLES, Thomas; MCPHERSON, Kirsty et al.Lung cancer. 2009, Vol 63, Num 1, pp 94-97, issn 0169-5002, 4 p.Article

Pemetrexed single agent in previously treated non-small cell lung cancer : A multi-institutional observational studyBEARZ, Alessandra; GARASSINO, Isabella; TIRELLI, Umberto et al.Lung cancer. 2008, Vol 60, Num 2, pp 240-245, issn 0169-5002, 6 p.Article